30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Vincent Milano

Track

Insider profile

Currently holds positions in Aclaris Therapeutics Inc and Idera Pharmaceuticals Inc

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 33% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Aclaris Therapeutics Inc Jan. 7, 2020 -
President, Chief Executive Officer, Director Idera Pharmaceuticals Inc Dec. 1, 2014 -
Independent Director Spark Therapeutics Inc June 1, 2014 - Dec. 17, 2019
Independent Director Vanda Pharmaceuticals Inc April 21, 2010 - June 1, 2019
Chairman of the Board, President, Chief Executive Officer Shire Viropharma Inc Dec. 31, 2008 - Jan. 24, 2014
Vincent Milano's trades of BioCryst Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-05-22 2024-05-20
B Purchase
72,244 +22.3%
496.12
US$1,600,505 		72,244 +22.3% 496.12 US$1,600,505
2024-05-22 2024-05-20
B Purchase
72,924 +32.4%
361.64
US$2,547,650 		72,924 +32.4% 361.64 US$2,547,650
2023-08-11 2023-08-10
S Sale
34,530 -40.2%
24.88
US$4,842,293 		34,530 -40.2% 24.88 US$4,842,293
2023-08-10 2023-08-10
PrS Proposed sale
3,283
0.58
US$1,904 		3,283 0.58 US$1,904
2021-11-24 2021-11-24
B Purchase
7,500 +75.0%
12.19
US$91,425 		7,500 +75.0% 12.19 US$91,425
2021-01-12 2021-01-12
S Sale
3,210 -1.5%
4.20
US$13,474 		3,210 -1.5% 4.20 US$13,474
2021-01-11 2021-01-05
S Sale
2,740 -1.3%
3.91
US$10,700 		2,740 -1.3% 3.91 US$10,700
2020-12-22 2020-12-22
PlS Planned sale
37,169 -14.8%
4.32
US$160,525 		37,169 -14.8% 4.32 US$160,525
2020-01-10 2020-01-07
S Sale
3,006 -3.4%
1.78
US$5,352 		3,006 -3.4% 1.78 US$5,352